➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Dow
McKinsey
Mallinckrodt
Baxter

Last Updated: June 25, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Co-trimoxazole


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Co-trimoxazole?

Co-trimoxazole is an investigational drug.

There have been 21 clinical trials for Co-trimoxazole. The most recent clinical trial was a Phase 3 trial, which was initiated on August 15th 2020.

The most common disease conditions in clinical trials are Infection, Communicable Diseases, and Arthritis, Infectious. The leading clinical trial sponsors are National Cancer Institute (NCI), Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh, and M.D. Anderson Cancer Center.

There are forty-six US patents protecting this investigational drug and seven hundred and eighty international patents.

Recent Clinical Trials for Co-trimoxazole
TitleSponsorPhase
The Role of High Dose Co-trimoxazole in Severe Covid-19 PatientsBangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshPhase 2/Phase 3
Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical CystectomyNational Cancer Institute (NCI)Phase 4
Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical CystectomyRoswell Park Cancer InstitutePhase 4

See all Co-trimoxazole clinical trials

Clinical Trial Summary for Co-trimoxazole

Top disease conditions for Co-trimoxazole
Top clinical trial sponsors for Co-trimoxazole

See all Co-trimoxazole clinical trials

US Patents for Co-trimoxazole

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Co-trimoxazole   Get Started Free Hamamelitannin analogues and uses thereof UNIVERSITEIT GENT (Ghent, BE)   Get Started Free
Co-trimoxazole   Get Started Free Systems and methods for treating bacterial infection Motif Biosciences Inc. (New York, NY)   Get Started Free
Co-trimoxazole   Get Started Free Systems and methods for treating bacterial infection Motif Biosciences Inc. (New York, NY)   Get Started Free
Co-trimoxazole   Get Started Free Hybrid polymer stent fabricated by a non-laser cut fabrication method   Get Started Free
Co-trimoxazole   Get Started Free Treatment of inflammatory disorders in non-human mammals THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, CA)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Co-trimoxazole

Drugname Country Document Number Estimated Expiration Related US Patent
Co-trimoxazole European Patent Office EP3166955 2034-07-08   Get Started Free
Co-trimoxazole World Intellectual Property Organization (WIPO) WO2016005340 2034-07-08   Get Started Free
Co-trimoxazole Australia AU2017260021 2036-05-04   Get Started Free
Co-trimoxazole Australia AU2019226171 2036-05-04   Get Started Free
Co-trimoxazole Canada CA3023229 2036-05-04   Get Started Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
AstraZeneca
Merck
Boehringer Ingelheim
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.